<DOC>
	<DOC>NCT00687180</DOC>
	<brief_summary>A study with 20 de novo patients with autoimmune hepatitis, 10 receiving azathioprin and 10 receiving mycophenolat mofetil.</brief_summary>
	<brief_title>Mycophenolate vs Azathioprin in Autoimmune Hepatitis</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis, Autoimmune</mesh_term>
	<criteria>De novo autoimmune hepatitis Consent age below 18 pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2008</verification_date>
	<keyword>Prednisolone dosage</keyword>
</DOC>